Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Other financing activities (2017 - 2025)

Mesa Laboratories' Other financing activities history spans 9 years, with the latest figure at -$2.9 million for Q4 2025.

  • For Q4 2025, Other financing activities fell 96766.67% year-over-year to -$2.9 million; the TTM value through Dec 2025 reached $358000.0, down 97.85%, while the annual FY2025 figure was $887000.0, 92.57% down from the prior year.
  • Other financing activities for Q4 2025 was -$2.9 million at Mesa Laboratories, down from $1.1 million in the prior quarter.
  • Across five years, Other financing activities topped out at $12.2 million in Q1 2024 and bottomed at -$7.2 million in Q1 2023.
  • The 5-year median for Other financing activities is $712000.0 (2023), against an average of $800210.5.
  • The largest annual shift saw Other financing activities soared 6327.94% in 2022 before it crashed 96766.67% in 2025.
  • A 5-year view of Other financing activities shows it stood at $3.7 million in 2021, then tumbled by 90.95% to $335000.0 in 2022, then tumbled by 96.42% to $12000.0 in 2023, then crashed by 75.0% to $3000.0 in 2024, then plummeted by 96766.67% to -$2.9 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Other financing activities are -$2.9 million (Q4 2025), $1.1 million (Q2 2025), and $2.2 million (Q1 2025).